Recent Quotes (30 days)

You have no recent quotes
chg | %

Helix Biopharma Corp.  

(Public, TSE:HBP)   Watch this stock  
Find more results for HBP
0.000 (0.00%)
Oct 18 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.50 - 1.72
Open     -
Vol / Avg. 0.00/960.00
Mkt cap 87.12M
P/E     -
Div/yield     -
EPS -0.13
Shares 96.80M
Beta -0.04
Inst. own 0%
Oct 30, 2017
Q4 2017 Helix Biopharma Corp Earnings Release (Estimated) Add to calendar

Key stats and ratios

Q2 (Apr '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -490.72% -157.62%
Return on average equity - -193.47%
Employees 15 -
CDP Score - -


21 St Clair Ave E Suite 1100
+1-416-9253232 (Phone)
+1-416-9251551 (Fax)

Website links


Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that modulate the tumor microenvironment. The Company's technology platform, DOS47 yielded approximately two drug product candidates, L-DOS47 and vDOS47. L-DOS47 is an antibody protein conjugate where the urease component enzymatically converts naturally occurring urea to ammonia. L-DOS47 is under clinical study for the treatment of non-small cell lung cancer (NSCLC). L-DOS47 has completed preclinical testing and manufacturing development, following which, regulatory approvals are obtained in Poland and the United States to conduct Phase I/II and Phase I clinical studies. V-DOS47 is an antibody DOS47 conjugate that targets the vascular endothelial growth factor 2 receptor (VEGFR2).

Officers and directors

Sven Rohmann M.D., Ph.D. Chairman of the Board
Age: 52
Heman Chao Ph.D. Chief Executive Officer, Chief Scientific Officer
Age: 54
Photios Michalargias Chief Financial Officer
Age: 50
Steve Demas Chief Operating Officer
George J. Anders Director
Sylwester Eugeniusz Cacek Director
Theordore Witek Jr. Director
Slawomir Majewski M.D. Independent Director
Age: 57
Marek Jan Orlowski Independent Director
Age: 47